| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_616f7b1d1b9e3c904aba8ff2513922e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate |
2007-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383016fb881191743bb05f3dccb7e8c6 |
| publicationDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007129441-A1 |
| titleOfInvention |
Protection of cells from adverse external or intrinsic effects, cellular degeneration and death by n-acylethanolamines |
| abstract |
The present invention includes compositions and methods for treating diseases of the eye and skin by modulating the amount of intracellular calcium using transdermal or transcorneal delivery of one or more N-acylethanolamines in a carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298335-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114099487-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018271767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10912599-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8455494-B2 |
| priorityDate |
2003-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |